Cargando…

What We Know and Would Like to Know about CDKL5 and Its Involvement in Epileptic Encephalopathy

In the last few years, the X-linked serine/threonine kinase cyclin-dependent kinase-like 5 (CDKL5) has been associated with early-onset epileptic encephalopathies characterized by the manifestation of intractable epilepsy within the first weeks of life, severe developmental delay, profound hypotonia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kilstrup-Nielsen, Charlotte, Rusconi, Laura, La Montanara, Paolo, Ciceri, Dalila, Bergo, Anna, Bedogni, Francesco, Landsberger, Nicoletta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3385648/ https://www.ncbi.nlm.nih.gov/pubmed/22779007 http://dx.doi.org/10.1155/2012/728267

Ejemplares similares

CDKL5 and Shootin1 Interact and Concur in Regulating Neuronal Polarization
por: Nawaz, Mohammad Sarfaraz, et al.
Publicado: (2016)

Extrasynaptic N-Methyl-d-aspartate (NMDA) Receptor Stimulation Induces Cytoplasmic Translocation of the CDKL5 Kinase and Its Proteasomal Degradation
por: Rusconi, Laura, et al.
Publicado: (2011)

CDKL5 localizes at the centrosome and midbody and is required for faithful cell division
por: Barbiero, Isabella, et al.
Publicado: (2017)

Characterisation of CDKL5 Transcript Isoforms in Human and Mouse
por: Hector, Ralph D., et al.
Publicado: (2016)

Contagious itch: what we know and what we would like to know
por: Schut, C., et al.
Publicado: (2015)

Editorial: Prostate Cancer: What We Know and What We Would Like to Know
por: Taverna, Gianluigi, et al.
Publicado: (2015)

Plant hormone transporters: what we know and what we would like to know
por: Park, Jiyoung, et al.
Publicado: (2017)

The Etiology and Pathology of Dental Diseases: What We Know, and What We Would like to Know
por: Sewill, Henry
Publicado: (1882)

Recurrent occurrences of CDKL5 mutations in patients with epileptic encephalopathy
por: Yamamoto, Toshiyuki, et al.
Publicado: (2015)

CDKL5 Deficiency Disorder—A Complex Epileptic Encephalopathy
por: Jakimiec, Martyna, et al.
Publicado: (2020)

Epileptic spasms with terror during sleep in CDKL5 encephalopathy
por: Melikishvili, Gia, et al.
Publicado: (2022)

Higgs sector: What we would like to know
por: Petrucciani, Giovanni
Publicado: (2020)

Higgs sector: What we would like to know
por: Petrucciani, Giovanni
Publicado: (2020)

Higgs sector: What we would like to know
por: Petrucciani, Giovanni
Publicado: (2020)

COVID-19 Catatonia—Would We Even Know?
por: Cooper, Joseph J., et al.
Publicado: (2020)

Investigating emotions in Parkinson's disease: what we know and what we still don't know
por: Sotgiu, Igor, et al.
Publicado: (2013)

Complex CDKL5 translational regulation and its potential role in CDKL5 deficiency disorder
por: Ruggiero, Valeria, et al.
Publicado: (2023)

What We Know and Don't Know About Lyme Disease
por: Donta, Sam T.
Publicado: (2022)

What We Know and What We Don't Know About Preventing Stroke
por: Burch, Druin
Publicado: (2014)

Microtubules: A Key to Understand and Correct Neuronal Defects in CDKL5 Deficiency Disorder?
por: Barbiero, Isabella, et al.
Publicado: (2019)

What We Know and Do Not Know about Sex and Cardiac Disease
por: Konhilas, John P.
Publicado: (2010)

The Role of the Microbiome in Autism: All That We Know about All That We Don’t Know
por: David, Maude M.
Publicado: (2021)

Therapeutic potential of pregnenolone and pregnenolone methyl ether on depressive and CDKL5 deficiency disorders: Focus on microtubule targeting
por: Barbiero, Isabella, et al.
Publicado: (2021)

Transcranial Electrical Stimulation: What We Know and Do Not Know About Mechanisms
por: Fertonani, Anna, et al.
Publicado: (2016)

What we know and what we need to know about the origin of SARS-CoV-2
por: Domingo, Jose L.
Publicado: (2021)

Thymic neuroendocrine neoplasms—what we know, what we don’t know, and what to do about it
por: Lang, Matthias, et al.
Publicado: (2023)

What do we know about neutrinos?
por: Vannucci, François
Publicado: (1994)

Bacteria and What We Know about Them
por: Fort, J. M.
Publicado: (1905)

What do we know about pseudodementia?
por: Mouta, Salomé, et al.
Publicado: (2023)

MeCP2 post-translational modifications: a mechanism to control its involvement in synaptic plasticity and homeostasis?
por: Bellini, Elisa, et al.
Publicado: (2014)

The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivo
por: Trovò, L., et al.
Publicado: (2020)

The origin of life: what we know, what we can know and what we will never know
por: Pross, Addy, et al.
Publicado: (2013)

What We Know and What We Need to Know about Aromatic and Cationic Biogenic Amines in the Gastrointestinal Tract
por: Fernández-Reina, Alberto, et al.
Publicado: (2018)

International Trade and Investment and Food Systems: What We Know, What We Don’t Know, and What We Don’t Know We Don’t Know
por: Schram, Ashley, et al.
Publicado: (2020)

Microplastics in freshwater ecosystems: what we know and what we need to know
por: Wagner, Martin, et al.
Publicado: (2014)

Will E-Monitoring of Policy and Program Implementation Stifle or Enhance Practice? How Would We Know?
por: Conte, Kathleen P., et al.
Publicado: (2018)

What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008)

Statin Intolerance—We Know Everything, We Know Nothing
por: Banach, Maciej
Publicado: (2022)

Big Tau: What We Know, and We Need to Know
por: Fischer, Itzhak
Publicado: (2023)

Zika: what we know and don't know
por: Diop, Doudou, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_e20nqc41gc5mi7m9uquorshva8